Description

This passively managed investment vehicle aims to broadly replicate the price movements and income generated by the NYSE Arca Biotechnology IndexSM, before any fees and expenses are deducted. The underlying "Index" is constructed using a modified equal-weighting methodology and tracks the performance of a diverse group of companies within the biotechnology sector, primarily those engaged in leveraging biological processes to develop products or provide specialized services.